4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
MediWound Ltd. (MDWD) operates in the Biotechnology industry and is headquartered in Yavne, Israel with about 121 employees. Its market capitalization is roughly $188 million. In the fiscal year ended 2025-12-31, MDWD reported $17M in revenue and ($24M) in net income.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally.
Interactive charts & full statements → Open the MDWD valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $17M | $20M | $19M | $26M | — |
| Gross Profit | $3M | $3M | $4M | $13M | — |
| Operating Income (EBIT) | ($25M) | ($19M) | ($16M) | ($8M) | — |
| Net Income | ($24M) | ($30M) | ($7M) | ($20M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $2M | $2M | $5M | $6M | $4M | — |
| Gross Profit | $0M | $0M | $1M | $1M | $1M | — |
| Operating Income (EBIT) | ($8M) | ($8M) | ($6M) | ($6M) | ($5M) | — |
| Net Income | ($3M) | ($7M) | ($3M) | ($13M) | ($1M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $86M | $74M | $66M | $50M | — |
| Total Liabilities | $43M | $42M | $35M | $39M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MDWD viewer.
About TickerBase · Data methodology & sources